Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'.
Publication
, Journal Article
Pieske, B; Armstrong, PW; VICTORIA Study Group
Published in: Eur J Heart Fail
August 2023
Duke Scholars
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
August 2023
Volume
25
Issue
8
Start / End Page
1470 / 1471
Location
England
Related Subject Headings
- Pyrimidines
- Humans
- Heterocyclic Compounds, 2-Ring
- Heart Failure
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pieske, B., Armstrong, P. W., & VICTORIA Study Group. (2023). Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'. Eur J Heart Fail, 25(8), 1470–1471. https://doi.org/10.1002/ejhf.2964
Pieske, Burkert, Paul W. Armstrong, and VICTORIA Study Group. “Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'.” Eur J Heart Fail 25, no. 8 (August 2023): 1470–71. https://doi.org/10.1002/ejhf.2964.
Pieske B, Armstrong PW, VICTORIA Study Group. Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'. Eur J Heart Fail. 2023 Aug;25(8):1470–1.
Pieske, Burkert, et al. “Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'.” Eur J Heart Fail, vol. 25, no. 8, Aug. 2023, pp. 1470–71. Pubmed, doi:10.1002/ejhf.2964.
Pieske B, Armstrong PW, VICTORIA Study Group. Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'. Eur J Heart Fail. 2023 Aug;25(8):1470–1471.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
August 2023
Volume
25
Issue
8
Start / End Page
1470 / 1471
Location
England
Related Subject Headings
- Pyrimidines
- Humans
- Heterocyclic Compounds, 2-Ring
- Heart Failure
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology